Treatment with candesartan was associated with a reduction in median (IQR) urine AGT/creatinine from 23.5 (1.6, 105.1) to 2.0 (1.4, 13.7) μ g/g, which did not reach statistical significance.
← all excerpts
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.
1
—
—